Page last updated: 2024-08-24

arctigenin and Triple Negative Breast Neoplasms

arctigenin has been researched along with Triple Negative Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lee, KS; Lee, MG; Nam, KS1
Huang, Q; Ji, J; Liu, P; Liu, X; Liu, Y; Ma, W; Qin, S; Sun, Z; Yuan, X; Zhang, J; Zhang, L; Zhang, Y1
Cao, W; Feng, T; Gu, X; Guo, Y; Li, J; Li, S; Liu, X; Liu, Y; Shen, W; Tsai, HI; Wu, F; Zhang, J; Zhang, L1

Other Studies

3 other study(ies) available for arctigenin and Triple Negative Breast Neoplasms

ArticleYear
Anti‑metastatic effects of arctigenin are regulated by MAPK/AP‑1 signaling in 4T‑1 mouse breast cancer cells.
    Molecular medicine reports, 2020, Volume: 21, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Arctium; Cell Line, Tumor; Cell Movement; Female; Furans; Humans; Lignans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Transcription Factor AP-1; Triple Negative Breast Neoplasms

2020
Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
    Oncology reports, 2017, Volume: 38, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Autoantigens; Cell Line, Tumor; Down-Regulation; Furans; Humans; Intracellular Signaling Peptides and Proteins; Lignans; Membrane Proteins; Phosphorylation; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms

2017
Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy.
    Oncotarget, 2017, Jan-03, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arctium; Asia, Eastern; Cell Line, Tumor; Cell Proliferation; DNA; Docetaxel; Drug Evaluation, Preclinical; Drug Synergism; Female; Fluorescent Antibody Technique; Furans; Humans; Hydrogen Bonding; Lignans; Mice, Nude; Molecular Docking Simulation; Plants, Medicinal; Protein Domains; Signal Transduction; STAT3 Transcription Factor; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017